Structural basis of lentiviral subversion of a cellular protein degradation pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural basis of lentiviral subversion of a cellular protein degradation pathway
Authors
Keywords
-
Journal
NATURE
Volume 505, Issue 7482, Pages 234-238
Publisher
Springer Nature America, Inc
Online
2013-12-14
DOI
10.1038/nature12815
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIV-2 and SIVmac Accessory Virulence Factor Vpx Down-regulates SAMHD1 Enzyme Catalysis Prior to Proteasome-dependent Degradation
- (2013) Maria DeLucia et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tetramerization of SAMHD1 Is Required for Biological Activity and Inhibition of HIV Infection
- (2013) Junpeng Yan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evolutionary Toggling of Vpx/Vpr Specificity Results in Divergent Recognition of the Restriction Factor SAMHD1
- (2013) Oliver I. Fregoso et al. PLoS Pathogens
- Towards automated crystallographic structure refinement withphenix.refine
- (2012) Pavel V. Afonine et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- The Ability of Primate Lentiviruses to Degrade the Monocyte Restriction Factor SAMHD1 Preceded the Birth of the Viral Accessory Protein Vpx
- (2012) Efrem S. Lim et al. Cell Host & Microbe
- A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest
- (2012) Wei Wei et al. CELLULAR MICROBIOLOGY
- HIV/Simian Immunodeficiency Virus (SIV) Accessory Virulence Factor Vpx Loads the Host Cell Restriction Factor SAMHD1 onto the E3 Ubiquitin Ligase Complex CRL4DCAF1
- (2012) Jinwoo Ahn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates
- (2012) Hichem Lahouassa et al. NATURE IMMUNOLOGY
- SAMHD1 restricts HIV-1 infection in resting CD4+ T cells
- (2012) Hanna-Mari Baldauf et al. NATURE MEDICINE
- SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells
- (2012) Benjamin Descours et al. Retrovirology
- The Molecular Basis of CRL4DDB2/CSA Ubiquitin Ligase Architecture, Targeting, and Activation
- (2011) Eric S. Fischer et al. CELL
- HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase
- (2011) David C. Goldstone et al. NATURE
- SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
- (2011) Nadine Laguette et al. NATURE
- Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
- (2011) Kasia Hrecka et al. NATURE
- Exposed Hydrophobic Residues in Human Immunodeficiency Virus Type 1 Vpr Helix-1 Are Important for Cell Cycle Arrest and Cell Death
- (2011) R. Anthony Barnitz et al. PLoS One
- Integration, scaling, space-group assignment and post-refinement
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome
- (2010) Harriet CT Groom et al. Retrovirology
- The Human Immunodeficiency Virus Type 2 Vpx Protein Usurps the CUL4A-DDB1DCAF1 Ubiquitin Ligase To Overcome a Postentry Block in Macrophage Infection
- (2009) A. Bergamaschi et al. JOURNAL OF VIROLOGY
- A promiscuous α-helical motif anchors viral hijackers and substrate receptors to the CUL4–DDB1 ubiquitin ligase machinery
- (2009) Ti Li et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural Basis of UV DNA-Damage Recognition by the DDB1–DDB2 Complex
- (2008) Andrea Scrima et al. CELL
- Lentiviral Vpx Accessory Factor Targets VprBP/DCAF1 Substrate Adaptor for Cullin 4 E3 Ubiquitin Ligase to Enable Macrophage Infection
- (2008) Smita Srivastava et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started